中科微点-全球专利检索

  1. Login
  2. Sign Up

Search Results

1719 records (took 0.02 seconds)

    Detection of anomalous computing environment behavior using glucose
    35.
    发明授权
    Detection of anomalous computing environment behavior using glucose 有权

    公开(公告)号：US12002591B2

    公开(公告)日：2024-06-04

    申请号：US17455277

    申请日：2021-11-17

    Applicant: DexCom, Inc.

    Inventor： Sarah Kate Pickus ,  Brian Bober

    IPC: G16H50/70 ,  A61B5/00 ,  A61B5/145 ,  G16H10/60 ,  G16H40/67 ,  G16H50/20

    CPC classification number: G16H50/70 ,  A61B5/14532 ,  A61B5/6801 ,  A61B5/7278 ,  A61B5/742 ,  A61B5/746 ,  G16H10/60 ,  G16H40/67 ,  G16H50/20

    Abstract: Detection of anomalous computing environment behavior using glucose is described. An anomaly detection system receives glucose measurements and event records during a first time period. Missing events that are missing from the event records during the first time period are identified by processing the glucose measurements using an event engine simulator. An anomaly detection model is generated based on the missing events during the first time period. Subsequently, the anomaly detection system receives additional glucose measurements and additional event records during a second time period. Missing events that are missing from the additional event records during the second time period are identified by processing the additional glucose measurements using the event engine simulator. Anomalous behavior is detected if the identified missing events that are missing from the event records during the second time period are outside a predicted range of missing events of the anomaly detection model.

    MEDICAMENT INJECTION PEN WITH AUTOMATIC DOSING
    36.
    发明公开
    MEDICAMENT INJECTION PEN WITH AUTOMATIC DOSING 审中-公开

    公开(公告)号：US20240173471A1

    公开(公告)日：2024-05-30

    申请号：US18502453

    申请日：2023-11-06

    Applicant: Dexcom, Inc.

    Inventor： Edward J. Sweeney

    IPC: A61M5/142

    CPC classification number: A61M5/14244

    Abstract: Automatic medicament dosing is described. A dose of a medicament to administer to a user via a medicament injection pen is calculated based on analyte monitoring data. A user input to initiate an injection of the medicament is received, and the medicament injection pen is operated to administer the calculated dose to the user in response to receiving the user input. In one or more implementations, operating the medicament pump to administer the calculated dose to the user includes powering a motorized pump of the medicament injection pen to flow the calculated dose from a medicament reservoir through a needle. In one or more implementations, the medicament pen is communicatively coupled to a computing device, and operating the medicament pump to administer the calculated dose to the user is further in response to the medicament injection pen receiving instructions to administer the calculated dose from the computing device.

    ANALYTE SENSOR
    38.
    发明公开
    ANALYTE SENSOR 审中-公开

    公开(公告)号：US20240138720A1

    公开(公告)日：2024-05-02

    申请号：US18516661

    申请日：2023-11-21

    Applicant: Dexcom, Inc.

    Inventor： Ted Tang Lee ,  Andrew Trinin Dennis ,  Shanger Wang ,  Jiong Zou

    IPC: A61B5/145

    CPC classification number: A61B5/14532

    Abstract: Disclosed are devices for determining an analyte concentration. The devices comprise a sensor configured to generate a signal associated with a concentration of an analyte and an electronics unit operatively connected to the sensor. The electronics unit may be engaged with a housing that may secure the device to a host's skin. In this regard, in one embodiment, the housing may be attached to an adhesive patch that is fastened to the skin of the host.

    Glucose alert prediction horizon modification
    39.
    发明授权
    Glucose alert prediction horizon modification 有权

    公开(公告)号：US11969267B2

    公开(公告)日：2024-04-30

    申请号：US17464447

    申请日：2021-09-01

    Applicant: DexCom, Inc.

    Inventor： Lauren Hruby Jepson ,  Sarah Kate Pickus ,  Joost van der Linden

    IPC: A61B5/00 ,  A61B5/145 ,  G16H40/67 ,  G16H50/30

    CPC classification number: A61B5/7275 ,  A61B5/14532 ,  A61B5/7267 ,  A61B5/746 ,  G16H40/67 ,  G16H50/30 ,  A61B5/6833 ,  A61B2560/0487

    Abstract: Data describing glucose measurements is received from a continuous glucose monitoring (CGM) system worn by a user and predicted glucose values during a future time period are generated for the user based on the data. A determination is made that at least one of the predicted glucose values satisfies a threshold value for an alert, which is associated with a prediction horizon that defines an amount of time prior to satisfaction of the threshold value for communicating the alert to the user. Output of the alert is caused responsive to determining that the at least one predicted glucose value satisfies the threshold value for the alert within the prediction horizon, relative to a current time. The prediction horizon is modified based on a user response to the alert. Output of a subsequent instance of the alert is caused based on the modified prediction horizon.

Patent Agency Ranking